1lp1: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
|PDB= 1lp1 |SIZE=350|CAPTION= <scene name='initialview01'>1lp1</scene>, resolution 2.3Å | |PDB= 1lp1 |SIZE=350|CAPTION= <scene name='initialview01'>1lp1</scene>, resolution 2.3Å | ||
|SITE= | |SITE= | ||
|LIGAND= <scene name='pdbligand= | |LIGAND= <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene> | ||
|ACTIVITY= | |ACTIVITY= | ||
|GENE= | |GENE= | ||
|DOMAIN= | |||
|RELATEDENTRY=[[2spz|2spz]] | |||
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1lp1 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1lp1 OCA], [http://www.ebi.ac.uk/pdbsum/1lp1 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1lp1 RCSB]</span> | |||
}} | }} | ||
| Line 26: | Line 29: | ||
[[Category: Nordlund, P.]] | [[Category: Nordlund, P.]] | ||
[[Category: Nygren, P A.]] | [[Category: Nygren, P A.]] | ||
[[Category: affibody]] | [[Category: affibody]] | ||
[[Category: in vitro evolved]] | [[Category: in vitro evolved]] | ||
| Line 33: | Line 34: | ||
[[Category: three-helix bundle]] | [[Category: three-helix bundle]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 22:05:34 2008'' | ||
Revision as of 22:05, 30 March 2008
| |||||||
| , resolution 2.3Å | |||||||
|---|---|---|---|---|---|---|---|
| Ligands: | , | ||||||
| Related: | 2spz
| ||||||
| Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
Protein Z in complex with an in vitro selected affibody
OverviewOverview
The broad binding repertoire of antibodies has permitted their use in a wide range of applications. However, some uses of antibodies are precluded due to limitations in the efficiency of antibody generation. In vitro evolved binding proteins, selected from combinatorial libraries generated around various alternative structural scaffolds, are promising alternatives to antibodies. We have solved the crystal structure of a complex of an all alpha-helical in vitro selected binding protein (affibody) bound to protein Z, an IgG Fc-binding domain derived from staphylococcal protein A. The structure of the complex reveals an extended and complementary binding surface with similar properties to protein-antibody interactions. The surface region of protein Z recognized by the affibody is strikingly similar to the one used for IgG(1) Fc binding, suggesting that this surface contains potential hot-spots for binding. The implications of the selected affibody binding-mode for its application as a universal binding protein are discussed.
About this StructureAbout this Structure
1LP1 is a Single protein structure of sequence from Staphylococcus aureus. Full crystallographic information is available from OCA.
ReferenceReference
Structural basis for recognition by an in vitro evolved affibody., Hogbom M, Eklund M, Nygren PA, Nordlund P, Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3191-6. Epub 2003 Feb 25. PMID:12604795
Page seeded by OCA on Sun Mar 30 22:05:34 2008